(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9650370
APP PUB NO 20160102085A1
SERIAL NO

14891051

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to novel (Cyano-dimethyl-methyl)-isoxazolesand-[1,3,4]thiadiazoles and their use as CB2 cannabinoid receptor agonists, pharmaceutical compositions containing the same, and their use for the treatment of CB2 receptor mediated disorders or conditions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTREXION THERAPEUTICS CORPORATION509 SOUTH EXETER STREET BALTIMORE MD 21202

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Binder, Florian Paul Christian Maselheim, DE 29 26
Doobs, Henri Warthausen, DE 2 4
Mueller, Stephan Georg Warthausen, DE 83 1029
Nicholson, Janet Rachel Oberhoefen, DE 13 29
Riether, Doris Biberach an der Riss, DE 53 1123
Sauer, Achim Ravensburg-Torkenweiler, DE 22 474

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 16, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00